ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 28 filers reported holding ELEVATION ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,271 | -56.4% | 3,427 | 0.0% | 0.00% | – |
Q2 2023 | $5,209 | -98.2% | 3,427 | -97.7% | 0.00% | – |
Q1 2023 | $282,055 | +258666.1% | 148,450 | +128987.0% | 0.00% | – |
Q4 2022 | $109 | – | 115 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 115 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 115 | -98.2% | 0.00% | – |
Q1 2022 | $16,000 | -66.7% | 6,339 | -19.8% | 0.00% | – |
Q4 2021 | $48,000 | +300.0% | 7,905 | +400.3% | 0.00% | – |
Q3 2021 | $12,000 | – | 1,580 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Qiming U.S. Ventures Management, LLC | 2,370,142 | $1,570,456 | 2.08% |
Aisling Capital Management LP | 2,834,910 | $1,878,411 | 0.77% |
venBio Partners LLC | 2,914,255 | $1,930,985 | 0.55% |
TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $2,650,400 | 0.37% |
Velan Capital Investment Management LP | 497,299 | $329,510 | 0.27% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $596,340 | 0.11% |
DAFNA Capital Management LLC | 450,000 | $298,170 | 0.09% |
Ikarian Capital, LLC | 1,171,939 | $776,527 | 0.09% |
CAXTON CORP | 21,813 | $14,453 | 0.06% |
BVF INC/IL | 2,312,200 | $1,532,064 | 0.04% |